Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $373.90 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $100.15 | 6 | $0 (2022) |
| Daiichi Sankyo Inc. | $36.99 | 2 | $0 (2021) |
| PFIZER INC. | $30.85 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $27.96 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.94 | 1 | $0 (2022) |
| Lilly USA, LLC | $23.35 | 1 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $21.28 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $20.82 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $19.94 | 1 | $0 (2022) |
| Amgen Inc. | $19.81 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $195.75 | 9 | Novo Nordisk Inc ($36.66) |
| 2021 | $151.52 | 9 | Novo Nordisk Inc ($47.87) |
| 2020 | $26.63 | 2 | Novo Nordisk Inc ($15.62) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Neurology | ||||||
| 11/17/2022 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRIJARDY XR | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: DIABETES | ||||||
| 10/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.70 | General |
| 09/21/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: PRIMARY CARE | ||||||
| 08/10/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 07/20/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Obesity | ||||||
| 12/11/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 07/16/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: GASTROINTESTINAL | ||||||
| 06/18/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Obesity | ||||||
| 05/18/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/14/2021 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Neurology | ||||||
| 05/11/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GASTROINTESTINAL | ||||||
| 05/04/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 04/09/2021 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Neuroscience | ||||||
| 01/12/2021 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/04/2020 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $11.01 | General |
| Category: Dental and Oral Health | ||||||
| 10/11/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 569 | 852 | $200,425 | $62,879 |
| 2022 | 7 | 335 | 438 | $88,218 | $27,009 |
| 2021 | 4 | 148 | 202 | $37,970 | $14,208 |
| 2020 | 1 | 11 | 11 | $1,705 | $775.46 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 285 | 523 | $101,334 | $32,281 | 31.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 140 | $39,049 | $13,086 | 33.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 99 | 99 | $28,596 | $8,786 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 55 | $27,649 | $7,445 | 26.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 35 | $3,796 | $1,281 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 194 | $45,590 | $12,973 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 48 | $14,640 | $4,333 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 70 | $10,850 | $3,767 | 34.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 53 | $10,123 | $2,980 | 29.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $5,610 | $2,740 | 48.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 11 | $825.00 | $134.09 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 29 | 29 | $580.00 | $83.07 | 14.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 101 | $23,710 | $8,876 | 37.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 64 | $9,920 | $3,658 | 36.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 22 | 26 | $3,900 | $1,474 | 37.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $440.00 | $200.20 | 45.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 11 | $1,705 | $775.46 | 45.5% |
About Kirankumar Patel
Kirankumar Patel is a Internal Medicine healthcare provider based in Upland, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2017. The National Provider Identifier (NPI) number assigned to this provider is 1679002083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kirankumar Patel has received a total of $373.90 in payments from pharmaceutical and medical device companies, with $195.75 received in 2022. These payments were reported across 20 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($373.90).
As a Medicare-enrolled provider, Patel has provided services to 1,063 Medicare beneficiaries, totaling 1,503 services with total Medicare billing of $104,872. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Upland, PA
- Active Since 06/08/2017
- Last Updated 08/03/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679002083
Products in Payments
- INJECTAFER (Drug) $36.99
- Saxenda (Drug) $32.58
- COLOGUARD DNA CAPTURE REAGENTS (Device) $30.85
- Ozempic (Drug) $30.75
- TOUJEO (Biological) $27.96
- JARDIANCE (Drug) $27.94
- TRULICITY (Drug) $23.35
- NURTEC ODT (Drug) $21.28
- TRELEGY ELLIPTA (Drug) $20.82
- REXULTI (Drug) $19.94
- Aimovig (Biological) $19.81
- APLENZIN (Drug) $17.80
- Wegovy (Drug) $17.12
- Dayvigo (Drug) $16.00
- (8874) inCourage (Device) $11.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Upland
Dr. Ghassan Hadi, M.d, M.D
Internal Medicine — Payments: $66,304
Dr. Larry Chan, D.o, D.O
Internal Medicine — Payments: $62,165
Susan Biegel, M.d, M.D
Internal Medicine — Payments: $9,625
Dr. Nicolaas Grobler, Md, MD
Internal Medicine — Payments: $9,457
Saman Sarani, M.d, M.D
Internal Medicine — Payments: $4,462
Dr. Michael Chai, M.d, M.D
Internal Medicine — Payments: $4,005